Journal Mobile Options
Table of Contents
Vol. 39, No. 6, 2003
Issue release date: December 2003
Pediatr Neurosurg 2003;39:291–298

Treatment of Spinal Involvement in Neuroblastoma Patients

Sandberg D.I. · Bilsky M.H. · Kushner B.H. · Souweidane M.M. · Kramer K. · Laquaglia M.P. · Panageas K.S. · Cheung N.-K.V.
aDepartment of Surgery, Division of Neurosurgery; Departments of bPediatrics, cSurgery and dEpidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Introduction: Considerable controversy exists regarding the appropriate management of spinal involvement in neuroblastoma (NB) patients. We review a large group of such patients and offer treatment recommendations. Methods: Forty-six patients with epidural and/or neural foraminal involvement treated between 1987 and 1998 were staged according to the International NB Staging System (INSS) and classified as high-risk (INSS stage 4; n = 31) or low-risk (INSS stage <4; n = 15). Of 13 high- risk patients with normal neurologic examinations and no radiographic high-grade spinal cord compression (HGSCC), 12 were treated initially with chemotherapy, and only 1 demonstrated neurologic deterioration. HGSCC was present in 18 patients with high-risk NB; 7 of 10 (70%) treated initially with chemotherapy and 6 of 6 (100%) managed initially with operation improved or remained stable. All 9 low-risk patients with normal neurologic examinations and no HGSCC remained neurologically intact following operations (n = 7) or chemotherapy (n = 2). All 4 low-risk patients with HGSCC treated with operations improved or remained stable, and 0 of 2 (0%) low-risk patients treated initially with chemotherapy remained stable. Spinal deformities occurred in 2 of 16 patients (12.5%) treated nonoperatively and in 9 of 30 (30.0%) who underwent operations. Conclusions: High-risk NB patients with spinal involvement but normal neurologic examinations should be offered chemotherapy. High-risk patients with HGSCC may respond to chemotherapy, but a small percentage will require operations for progressive neurologic deficits. Chemotherapy may be avoided in low-risk patients who are offered potentially curative operations. Patients treated with operations for epidural disease are at high risk of subsequently developing spinal deformity.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Miller RW, Young JL, Novakovic B: Childhood cancer. Cancer 1995;75:395–405.
  2. Bader KL, Miller RW: US cancer incidence and mortality in the first year of life. Am J Dis Child 1979;133:157–159.
  3. Kushner BH, Cheung N-KV, LaQuaglia MP, Ambros PF, Ambros IM, Bonilla MA, Ladanyi M, Gerald WF: International neuroblastoma staging system stage 1 neuroblastoma: A prospective study and literature review. J Clin Oncol 1996;14:2174–2180.
  4. Castleberry RP: Biology and treatment of neuroblastoma. Pediatr Clin North Am 1997;44:919–937.
  5. Punt J, Pritchard J, Pincott JR, Till K: Neuroblastoma: A review of 21 cases presenting with intra-spinal extension. Cancer 1980;45:3095–3101.
  6. Plantaz D, Rubie H, Michon J, Mechinaud F, Coze C, Chastagner P, Frappaz D, Gigaud M, Passagia JG, Hartman O: The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. Cancer 1996;78:311–319.
  7. King D, Goodman J, Hawk T, Boles ET, Sayers M: Dumbell neuroblastomas in children. Arch Surg 1975;110:888–891.
  8. Holgersen lO, Santulli TV, Schullinger JN, Berdon WE: Neuroblastoma with intraspinal (dumbell) extension. J Pediatr Surg 1983;18:406–411.
  9. Massad M, Haddad F, Slim M, Saba M, Nassar S, Abla A, Mansour A: Spinal cord compression in neuroblastoma. Surg Neurol 1985;23:567–572.
  10. Traggis DG, Filler RM, Druckman H, Jaffe N, Cassady JR: Prognosis for children with neuroblastoma presenting with paralysis. J Pediatr Surg 1977;12:419–425.
  11. Raffel C, Neave VC, Lavine S, McComb JG: Treatment of spinal cord compression by epidural malignancy in childhood. Neurosurgery 1991;28:349–352.
  12. Lewis DW, Packer RJ, Raney B, Rak IW, Belasco J, Lange B: Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. Pediatrics 1986;78:438–443.
  13. Conrad E, Olsewski AD, Berger M, Powell E, Bruckner J: Pediatric spine tumors with spinal cord compression. J Pediatr Orthop 1992;12:454–460.
  14. Mayfield JK, Riseborough EJ, Jaffe N, Nehme ME: Spinal deformity in children treated for neuroblastoma. J Bone Joint Surg Am 1981;63:183–193.
  15. Mayfield JK, Riseborough EJ, Jaffe N, Nehme ME: Irradiation spine deformity in children treated for neuroblastoma; in Late Biological Effects of Ionizing Radiation: Proceedings of the Symposium on the Late Biological Effects of Ionizing Radiation held by the International Atomic Energy Agency in Vienna, 13–17 March, 1978. Vienna, International Atomic Energy Agency, 1978, pp 155–165.
  16. King J, Stowe S: Results of spinal fusion for radiation scoliosis. Spine 1982;7:574–585.
  17. Lonstein JE: Post-laminectomy kyphosis. Clin Orthop 1977;128:93–100.

    External Resources

  18. Sanderson IR, Pritchard J, Marsh HT: Chemotherapy as the initial treatment of spinal cord compression due to disseminated neuroblastoma. J Neurosurg 1989;70:688–690.
  19. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Mattay KK, Castleberry RP: The international neuroblastoma pathology classification (the Shimada system). Cancer 1999;86:364–372.
  20. Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B: Terminology and morphologic criteria of neuroblastic tumors: Recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999;86:349–363.
  21. Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL: Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group experience – A pediatric oncology group study. J Clin Oncol 1998;16:2007–2017.
  22. Kushner BH, Cheung N-KV, LaQuaglia MP, Ambros PF, Ambros IM, Bonilla MA, Gerald WF, Ladanyi M, Gilbert F, Rosenfeld, NS, Yeh SDJ: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 1996;14:372–381.
  23. Brodeur GM, Seeger RC, Barrett A: International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol 1988;6:1874.
  24. Brodeur GM, Pritchard J, Berthold F, Carlesen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA: Revisions in the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466.
  25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
  26. Katzenstein HM, Kent PM, London WB, Cohn SL: Treatment an outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol 2001;19:1047–1055.
  27. De Bernardi B, Pianca C, Pistamiglio P, Veneselli E, Viscardi E, Pession A, Alvisi P, Carli M, Donfrancesco A, Casale F, Grazia Giolano M, Cordero di Montezemolo L, Di Cataldo A, Lo Curto M, Bagnulo S, Schumacher RS, Tamburini A, Garaventa A, Clement L, Bruzzi P: Neuroblastoma with symptomatic spinal cord compression at diagnosis: Treatment and results with 76 cases. J Clin Oncol 2001;19:183–190.
  28. Hoover M, Bowman LC, Crawford SE, Stack C, Donaldson JS, Grayhack JJ, Tomita T, Cohn SL: Long-term outcome of patients with intraspinal neuroblastoma. Med Pediatr Oncol 1999;32:353–359.
  29. Shikata J, Yamamuro T, Shimizu K, Saito T: Combined laminoplasty and posterolateral fusion for spinal canal surgery in children and adolescents. Clin Orthop 1990;259:92–99.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50